Pristiq Extended-Release 25 mg/1

Pristiq Extended-Release 25 mg is a selective serotonin-norepinephrine reuptake inhibitor (SNRI) used for managing depression. This extended-release tablet is designed for once-daily oral administration.

Pristiq Extended-Release 25 mg is primarily used to treat major depressive disorder (MDD). It works by affecting the balance of certain natural substances in the brain, which may help improve mood and emotional well-being. This medication is often prescribed for individuals who require long-term management of depressive symptoms.

Common effects of Pristiq Extended-Release 25 mg may include nausea, dizziness, dry mouth, and fatigue. Some users may also experience changes in appetite or sleep patterns. These effects are generally mild and may diminish as the body adjusts to the medication.

Pristiq Extended-Release 25 mg should be taken exactly as directed by a healthcare provider. It is important to avoid crushing, chewing, or breaking the extended-release tablets, as this can affect the drug's release mechanism. Always store the medication in a cool, dry place away from direct sunlight.

Pristiq Extended-Release 25 mg may interact with other medications, including monoamine oxidase inhibitors (MAOIs), selective serotonin reuptake inhibitors (SSRIs), and certain pain medications. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions.